BLLN

BillionToOne, Inc.

Price Chart

No historical data available

Latest Quote

$93.24

-1.91 (-2.01%)

Current Price

Previous Close	$95.15
Open	$95.15
Day High	$95.90
Day Low	$92.70
Volume	423,132

Fetched: 2026-08-31T10:54:29

Stock Information

Shares Outstanding	42.64M
Total Debt	$143.92M
Cash Equivalents	$548.63M
Revenue	$397.41M
Net Income	$33.18M
Sector	Healthcare
Industry	Diagnostics & Research
Market Cap	$4.28B
P/E Ratio	125.93
EPS (TTM)	$0.72
Exchange	NMS

🌐 Visit Website

Recent Price History

No history data available. Data will be fetched automatically.

About BillionToOne, Inc.

BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a list of mutations that are present in the tumor and types of mutations detected that include deletions, insertions, and point mutations; and Northstar Response, a methylation-based assay that quantifies the amount of cancer at the single molecule level without requiring a tissue biopsy, enabling real-time monitoring of patient response to therapy with unprecedented precision. BillionToOne, Inc. was incorporated in 2016 and is headquartered in Menlo Park, California.

📰 Latest News

No news articles available at the moment. Check back later for updates on BLLN.

Period:

Income Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31
Revenue
Reconciled Cost Of Revenue	$96,654,000	-	-
Cost Of Revenue	$96,654,000	-	-
Total Revenue	$305,112,000	-	-
Operating Revenue	$305,112,000	-	-
Expenses
Interest Expense	$95,000	-	-
Total Expenses	$289,089,000	-	-
Other Income Expense	$-15,919,000	-	-
Other Non Operating Income Expenses	$-15,919,000	-	-
Net Non Operating Interest Income Expense	$7,655,000	-	-
Interest Expense Non Operating	$95,000	-	-
Operating Expense	$192,435,000	-	-
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$7,454,000	-	-
Net Interest Income	$7,655,000	-	-
Interest Income	$7,750,000	-	-
Normalized Income	$7,454,000	-	-
Net Income From Continuing And Discontinued Operation	$7,454,000	-	-
Total Operating Income As Reported	$16,023,000	-	-
Net Income Common Stockholders	$2,919,000	-	-
Net Income	$7,454,000	-	-
Net Income Including Noncontrolling Interests	$7,454,000	-	-
Net Income Continuous Operations	$7,454,000	-	-
Pretax Income	$7,759,000	-	-
Special Income Charges	$0	-	-
Interest Income Non Operating	$7,750,000	-	-
Operating Income	$16,023,000	-	-
Gross Profit	$208,458,000	-	-
Per Share
Diluted EPS	$0.14	$-1.05	$-2.10
Basic EPS	$0.18	$-1.05	$-2.10
Other
Tax Effect Of Unusual Items	$0	-	-
Tax Rate For Calcs	$0	-	-
Normalized EBITDA (Bullshit earnings)	$19,761,000	-	-
Total Unusual Items	$0	-	-
Total Unusual Items Excluding Goodwill	$0	-	-
Reconciled Depreciation	$11,907,000	-	-
EBITDA (Bullshit earnings)	$19,761,000	-	-
EBIT	$7,854,000	-	-
Diluted Average Shares	$21,230,752	$39,433,000	$44,720,379
Basic Average Shares	$15,875,091	$39,433,000	$39,433,000
Diluted NI Availto Com Stockholders	$2,919,000	-	-
Otherunder Preferred Stock Dividend	$4,535,000	$0	$0
Tax Provision	$305,000	-	-
Research And Development	$49,384,000	-	-
Selling General And Administration	$143,051,000	-	-

Fetched: 2026-08-23

Balance Sheet (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31
Assets
Net Tangible Assets	$479,518,000	$-251,883,000	-
Total Assets	$632,654,000	-	-
Total Non Current Assets	$72,096,000	-	-
Other Non Current Assets	$4,993,000	-	-
Goodwill And Other Intangible Assets	$587,000	$227,000	-
Other Intangible Assets	$587,000	$227,000	-
Current Assets	$560,558,000	-	-
Other Current Assets	$5,421,000	-	-
Inventory	$17,545,000	-	-
Receivables	$41,617,000	-	-
Accounts Receivable	$41,617,000	-	-
Cash Cash Equivalents And Short Term Investments	$495,975,000	-	-
Cash And Cash Equivalents	$495,975,000	-	-
Debt
Total Debt	$108,895,000	-	-
Long Term Debt And Capital Lease Obligation	$103,297,000	-	-
Long Term Debt	$57,226,000	-	-
Current Debt And Capital Lease Obligation	$5,598,000	-	-
Liabilities
Total Liabilities Net Minority Interest	$152,549,000	-	-
Total Non Current Liabilities Net Minority Interest	$104,587,000	-	-
Non Current Deferred Liabilities	$1,290,000	$0	-
Current Liabilities	$47,962,000	-	-
Other Current Liabilities	$9,910,000	$271,000	-
Current Deferred Liabilities	$2,188,000	-	-
Payables And Accrued Expenses	$17,715,000	$10,671,000	-
Payables	$7,372,000	-	-
Total Tax Payable	$188,000	-	-
Accounts Payable	$7,184,000	-	-
Equity
Common Stock Equity	$480,105,000	-	-
Total Equity Gross Minority Interest	$480,105,000	-	-
Stockholders Equity	$480,105,000	-	-
Gains Losses Not Affecting Retained Earnings	$-1,792,000	$0	-
Other Equity Adjustments	$-1,792,000	-	-
Retained Earnings	$-274,747,000	-	-
Preferred Securities Outside Stock Equity	$0	-	-
Other
Ordinary Shares Number	$45,804,755	$44,720,379	$44,720,379
Share Issued	$45,804,755	$44,720,379	$44,720,379
Tangible Book Value	$479,518,000	$-251,883,000	-
Invested Capital	$537,331,000	-	-
Working Capital	$512,596,000	-	-
Capital Lease Obligations	$51,669,000	-	-
Total Capitalization	$537,331,000	-	-
Additional Paid In Capital	$756,644,000	-	-
Capital Stock	$0	-	-
Common Stock	$0	-	-
Non Current Deferred Revenue	$1,290,000	$0	-
Long Term Capital Lease Obligation	$46,071,000	-	-
Current Deferred Revenue	$2,188,000	-	-
Current Capital Lease Obligation	$5,598,000	-	-
Pensionand Other Post Retirement Benefit Plans Current	$12,551,000	-	-
Current Accrued Expenses	$10,343,000	$5,924,000	-
Net PPE	$66,516,000	$68,623,000	-
Accumulated Depreciation	$-23,265,000	$-17,149,000	-
Gross PPE	$89,781,000	-	-
Leases	$495,000	-	-
Construction In Progress	$2,224,000	-	-
Other Properties	$51,708,000	-	-
Machinery Furniture Equipment	$35,354,000	-	-
Properties	$0	-	-

Fetched: 2026-08-23

Cash Flow Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31
Free Cash Flow
Free Cash Flow	$15,673,000	-	-
Operating Activities
Operating Cash Flow	$24,595,000	-	-
Cash Flow From Continuing Operating Activities	$24,595,000	-	-
Operating Gains Losses	$7,419,000	-	-
Investing Activities
Capital Expenditure	$-8,922,000	-	-
Investing Cash Flow	$-8,922,000	-	-
Cash Flow From Continuing Investing Activities	$-8,922,000	-	-
Financing Activities
Repurchase Of Capital Stock	$0	-	-
Issuance Of Capital Stock	$292,044,000	-	-
Financing Cash Flow	$288,825,000	-	-
Cash Flow From Continuing Financing Activities	$288,825,000	-	-
Net Other Financing Charges	$-4,612,000	-	-
Net Preferred Stock Issuance	$0	-	-
Preferred Stock Issuance	$0	-	-
Net Common Stock Issuance	$292,044,000	-	-
Common Stock Issuance	$292,044,000	$0	$0
Other
Repayment Of Debt	$-1,777,000	-	-
Issuance Of Debt	$51,000	-	-
Interest Paid Supplemental Data	$4,651,000	-	-
Income Tax Paid Supplemental Data	$487,000	-	-
End Cash Position	$495,975,000	-	-
Beginning Cash Position	$191,477,000	-	-
Changes In Cash	$304,498,000	-	-
Proceeds From Stock Option Exercised	$3,119,000	-	-
Common Stock Payments	$0	-	-
Net Issuance Payments Of Debt	$-1,726,000	-	-
Net Long Term Debt Issuance	$-1,726,000	-	$12,961,000
Long Term Debt Payments	$-1,777,000	-	-
Long Term Debt Issuance	$51,000	-	$15,051,000
Net Investment Purchase And Sale	$0	-	-
Sale Of Investment	$0	-	-
Net Intangibles Purchase And Sale	$-41,000	$0	$0
Purchase Of Intangibles	$-41,000	$0	$0
Net PPE Purchase And Sale	$-8,881,000	-	-
Purchase Of PPE	$-8,881,000	-	-
Change In Working Capital	$-22,053,000	-	-
Change In Other Working Capital	$672,000	-	-
Change In Other Current Liabilities	$-4,393,000	-	-
Change In Other Current Assets	$-60,000	-	-
Change In Payables And Accrued Expense	$9,641,000	-	-
Change In Accrued Expense	$7,866,000	-	-
Change In Payable	$1,775,000	-	-
Change In Account Payable	$1,775,000	-	-
Change In Prepaid Assets	$-2,193,000	-	-
Change In Inventory	$-8,812,000	-	-
Change In Receivables	$-16,908,000	-	-
Changes In Account Receivables	$-16,908,000	-	-
Other Non Cash Items	$3,953,000	-	-
Stock Based Compensation	$15,915,000	-	-
Depreciation Amortization Depletion	$11,907,000	-	-
Depreciation And Amortization	$11,907,000	-	-
Depreciation	$11,907,000	-	-
Gain Loss On Investment Securities	$7,364,000	-	-
Gain Loss On Sale Of PPE	$55,000	-	-
Net Income From Continuing Operations	$7,454,000	-	-

Fetched: 2026-08-23